LaunchCyte, founded in 2000, is dedicated to creating life sciences companies that commercialize innovative healthcare technologies. The company identifies promising technologies from leading research universities and forms businesses to bring these innovations to market. LaunchCyte's portfolio includes five companies—Celsense, Crystalplex, Immunetrics, Knopp Biosciences, and Reaction Biology—offering solutions in healthcare, lighting, and display industries.
Notable affiliated individuals include experts from various scientific and business fields who contribute to the success of each portfolio company. LaunchCyte has garnered investments from both private and institutional investors, reflecting confidence in its mission and vision. Key achievements include the successful commercialization of groundbreaking technologies that improve healthcare outcomes. Overall, LaunchCyte has made a significant impact by translating academic research into practical applications that benefit society.
